Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Bristol-Myers Squibb(BMY) Benzinga·2024-11-09 03:35Bristol-Myers Squibb(BMY) Benzinga·2024-11-09 03:35
R1Bristol-Myers Squibb(BMY) Benzinga·2024-11-09 03:35